Market Price of VC Rose Slightly in July In China

Date: 2015-08-10

“On 9 July, 2015, the SAIC issued the exposure drafts of drugs and health care, which belong to the new Advertisement Law. The strict new rules may promote the transformation of marketing mode in health-care and pharmaceutical industries, regulate the competition between enterprises and safeguard the legal rights and interests of consumers.

Since many domestic manufacturers suspended production for an overhaul, the market price of VC rose slightly in July. CCM predicted that the price of VC would remain stable and even experience a slight increase in the coming two months.

Two factors add more pressure for domestic VE enterprises: the continuous euro depreciation worsened the export of domestic VE in the first half of 2015; the market price of VE was in decline in China, which made it be close to the production cost.

In July 2015, PKU Healthcare announced to divest its API business to Synthetic Group and Synthetic Group’s subsidiary. This will promote the development of medical business and pharmaceutical business.

In July 2015, Garden Bio-chemical indicated that it will continue to invest in new VD3 projects with high added values. This will help the comapny to further extend the VD3 industry chain from upstream to downstream.

In July 2015, Kingdomway planned to carry out VA oil and VD3 oil expansion projects and to acquire Vitatec (a health-care product company based in the US).

In July 2015, the main domestic manufacturers raised VB2’s selling price in succession, because of increased environmental burden and enterprises’ losses. However, it’s estimated that the market price of VB2 will not rise significantly in a short term, as manufacturers had large inventory and downstream enterprises have already purchased large amount of VB2 before price increase, under the background of VB2 market involved in the doldrums in H1 2015

Chinese Vitamins Imp. & Exp., May 2015

From Jan. to May 2015, the export value of VA dropped year on year, because both its export price and export volume decreased.

In the first half of 2015, the export volume of China’s VB1 dropped dramatically because EU enhanced their import standard and the export price increased year on year.

Market prices of vitamins in China, July 2015

In June-July 2015, VB12 market remains stable: price maintains high level but slight fluctuation, supply and demand trends to balance. It’s estimated that VB12 price will maintain stable in a short period.

Since mid-May 2015, the market price of VK3 in China rebounded dramatically, which was fueled by the increasing price of raw material and manufacturers deliberately lifting its price.

In H1 2015, VB9 (folic acid) price has showed an uptrend in the domestic market, driven by the short supply. It’s estimated that VB9 price is likely to keep stable or go down in H2, due to the supply shortage to be eased.”

“According to data from the National Bureau of Statistics (NBS), the preliminary accounting GDP reached USD4.85 trillion (RMB29.69 trillion) in the first half of 2015, with a 7.0% year-on-year growth rate.  Specifically,

Data from NBS showed that China economy is under a stable rise.

In July 2015, the domestic vitamin market had an upturn. The market price of VC maintained an uptrend, as many domestic manufacturers suspended production for an overhaul. It’s predicted that the price of VC would remain stable and even experience an increase in a short term. Domestic VB2 manufacturers raised the product’s selling price, because of increased environmental burden and enterprises’ losses. In H1, the market price of VB9 (folic acid) underwent a surge, driven by the short supply. And its price still remains high now. Since mid-May 2015, the market price of VK3 in China rebounded dramatically, due to the increasing price of raw material and manufacturers deliberately lifting its price. At present, VB12 market remains stable: price maintains high level but slight fluctuation, supply and demand trends to balance. It’s estimated that VB12 price will maintain stable in a short period.

The USD/RMB exchange rate in this issue is USD1.00=RMB6.1149 on 1 July, 2015, sourced from the People’s Bank of China. All the prices mentioned in this report will include the VAT unless otherwise specified.”

Categories

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample